Amneal Pharmaceuticals (AMRX) Short Interest Ratio & Short Volume $7.21 -0.08 (-1.10%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$7.33 +0.12 (+1.65%) As of 05:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amneal Pharmaceuticals Short Interest DataAmneal Pharmaceuticals (AMRX) has a short interest of 5.36 million shares, representing 3.73% of the float (the number of shares available for trading by the public). This marks a -12.13% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 1.44 million shares to cover all short positions.Current Short Interest5,360,000 sharesPrevious Short Interest6,100,000 sharesChange Vs. Previous Month-12.13%Dollar Volume Sold Short$40.20 millionShort Interest Ratio2.6 Days to CoverLast Record DateMay 15, 2025Outstanding Shares313,420,000 sharesFloat Size143,560,000 sharesShort Percent of Float3.73%Today's Trading Volume1,034,703 sharesAverage Trading Volume1,440,577 sharesToday's Volume Vs. Average72% Short Selling Amneal Pharmaceuticals? Sign up to receive the latest short interest report for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAMRX Short Interest Over TimeAMRX Days to Cover Over TimeAMRX Percentage of Float Shorted Over Time Amneal Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20255,360,000 shares $40.20 million -12.1%3.7%2.6 $7.50 4/30/20256,100,000 shares $46.73 million +24.7%4.4%3.2 $7.66 4/15/20254,890,000 shares $35.06 million +10.4%3.6%2.8 $7.17 3/31/20254,430,000 shares $37.12 million +38.4%3.2%2.7 $8.38 3/15/20253,200,000 shares $28 million +15.9%2.4%2.2 $8.75 2/28/20252,760,000 shares $23.93 million +5.3%2.1%2.1 $8.67 2/15/20252,620,000 shares $20.25 million +8.3%2.0%2.2 $7.73 1/31/20252,420,000 shares $19.99 million -18.0%1.9%2 $8.26 1/15/20252,950,000 shares $24.25 million -10.6%2.3%2.6 $8.22 12/31/20243,300,000 shares $26.14 million -6.8%2.6%3.1 $7.92 Get the Latest News and Ratings for AMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/20243,540,000 shares $27.72 million -24.2%2.8%3.3 $7.83 11/30/20244,670,000 shares $38.62 million +4.2%3.7%4.2 $8.27 11/15/20244,480,000 shares $37.95 million +28.0%3.5%4.1 $8.47 10/31/20243,500,000 shares $29.65 million -16.3%2.9%2.9 $8.47 10/15/20244,180,000 shares $36.83 million -7.7%3.5%3.4 $8.81 9/30/20244,530,000 shares $37.69 million -2.4%3.8%3.5 $8.32 9/15/20244,640,000 shares $40.00 million +8.7%3.9%3.2 $8.62 8/31/20244,270,000 shares $36.98 million +0.2%3.6%2.9 $8.66 8/15/20244,260,000 shares $33.70 million -4.1%3.6%2.9 $7.91 7/31/20244,440,000 shares $32.55 million -3.3%4.0%3.1 $7.33 7/15/20244,590,000 shares $33.87 million +1.6%4.1%3 $7.38 6/30/20244,520,000 shares $28.70 million +24.9%4.1%2.9 $6.35 6/15/20243,620,000 shares $24.94 million +0.3%3.3%2.4 $6.89 5/31/20243,610,000 shares $24.11 million +17.6%3.3%2.3 $6.68 5/15/20243,070,000 shares $21.09 million +29.5%2.8%1.9 $6.87 4/30/20242,370,000 shares $14.34 million -15.4%2.3%1.5 $6.05 4/15/20242,800,000 shares $15.51 million +16.7%2.5%1.8 $5.54 3/31/20242,400,000 shares $14.54 million +15.9%2.2%1.6 $6.06 3/15/20242,070,000 shares $11.39 million +13.1%1.9%1.4 $5.50 2/29/20241,830,000 shares $10.10 million -12.9%1.7%1.2 $5.52 2/15/20242,100,000 shares $12.37 million -17.3%1.9%1.5 $5.89 1/31/20242,540,000 shares $13.59 million +1.6%2.3%1.9 $5.35 12/15/20232,650,000 shares $13.75 million -16.7%2.4%1.9 $5.19 11/30/20233,180,000 shares $13.71 million -12.2%5.8%2.5 $4.31 11/15/20233,620,000 shares $16.25 million +13.5%6.5%2.9 $4.49 10/31/20233,190,000 shares $12.33 million +4.3%3.1%2.6 $3.87 10/15/20233,060,000 shares $11.75 million -20.5%3.0%2.4 $3.84 9/30/20233,850,000 shares $16.25 million +4.3%3.7%3.4 $4.22 9/15/20233,690,000 shares $15.17 million +1.9%3.6%3.4 $4.11 8/31/20233,620,000 shares $14.81 million +3.7%3.5%3.1 $4.09Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 8/15/20233,490,000 shares $13.66 million -3.6%3.4%3 $3.92 7/31/20233,620,000 shares $11.58 million -12.8%3.6%3.3 $3.20 7/15/20234,150,000 shares $12.57 million +0.2%4.1%4 $3.03 6/30/20234,140,000 shares $12.83 million -4.6%4.1%3.9 $3.10 6/15/20234,340,000 shares $11.72 million -13.6%4.3%4.4 $2.70 5/31/20235,020,000 shares $11.75 million +7.3%4.9%5.3 $2.34 5/15/20234,680,000 shares $9.45 million -24.8%4.6%4.9 $2.02 4/30/20236,220,000 shares $12.00 million -9.9%6.3%6.2 $1.93 4/15/20236,900,000 shares $9.38 million +7.1%6.9%6.3 $1.36 3/31/20236,440,000 shares $8.95 million -13.1%6.5%6.1 $1.39 3/15/20237,410,000 shares $10.08 million +4.1%8.9%6.6 $1.36 2/28/20237,120,000 shares $14.67 million -11.7%7.2%5.5 $2.06 2/15/20238,060,000 shares $20.23 million -11.5%8.1%6.6 $2.51 1/31/20239,110,000 shares $20.04 million +10.6%9.1%7.1 $2.20 1/15/20238,240,000 shares $18.29 million +6.5%8.3%7.1 $2.22 12/30/20227,740,000 shares $15.40 million +142.6%7.8%6.8 $1.99 12/15/20223,190,000 shares $7.24 million -12.6%3.3%2.9 $2.27 11/30/20223,650,000 shares $9.34 million -15.3%3.8%3.5 $2.56 11/15/20224,310,000 shares $9.91 million -7.9%4.5%4.4 $2.30 10/31/20224,680,000 shares $10.30 million -2.9%4.8%4 $2.20 10/15/20224,820,000 shares $9.45 million +2.6%5.0%4.3 $1.96 9/30/20224,700,000 shares $9.49 million +2.2%4.8%4.3 $2.02 9/15/20224,600,000 shares $10.81 million +15.3%4.7%4.3 $2.35 8/31/20223,990,000 shares $8.66 million +7.3%4.1%3.9 $2.17 8/15/20223,720,000 shares $11.87 million +9.4%3.8%4.1 $3.19 7/31/20223,400,000 shares $12.04 million -6.6%3.5%4.9 $3.54 7/15/20223,640,000 shares $11.39 million -3.7%3.8%5.3 $3.13 6/30/20223,780,000 shares $12.02 million -9.1%3.9%5.1 $3.18 6/15/20224,160,000 shares $13.98 million -1.0%4.6%5.6 $3.36 5/31/20224,200,000 shares $15.25 million +7.7%4.4%5.6 $3.63 5/15/20223,900,000 shares $13.46 million +3.7%4.0%5.1 $3.45 4/30/20223,760,000 shares $14.51 million +10.3%3.9%5 $3.86 4/15/20223,410,000 shares $14.05 million +6.9%3.5%5 $4.12 3/31/20223,190,000 shares $13.30 million -0.9%3.3%5 $4.17 3/15/20223,220,000 shares $12.78 million +9.9%3.4%4.9 $3.97 2/28/20222,930,000 shares $13.27 million +1.0%3.1%4.5 $4.53 2/15/20222,900,000 shares $13.72 million +30.0%3.0%4.4 $4.73 1/31/20222,230,000 shares $9.88 million +4.7%2.3%3.2 $4.43 1/15/20222,130,000 shares $9.88 million -19.3%2.2%2.8 $4.64 12/31/20212,640,000 shares $12.65 million -6.7%2.8%3.4 $4.79 12/15/20212,830,000 shares $11.72 million +8.0%3.0%3.4 $4.14 11/30/20212,620,000 shares $10.95 million -15.2%2.7%3.1 $4.18 11/15/20213,090,000 shares $15.94 million -3.7%3.2%3.1 $5.16 10/29/20213,210,000 shares $17.62 million -5.3%3.4%3.1 $5.49 10/15/20213,390,000 shares $19.12 million -5.8%3.5%3.5 $5.64 9/30/20213,600,000 shares $19.22 million -10.9%3.8%3.3 $5.34 9/15/20214,040,000 shares $20.00 million -9.2%4.2%3.7 $4.95 8/31/20214,450,000 shares $25.10 million -2.4%4.7%4.3 $5.64 8/13/20214,560,000 shares $23.30 million -4.4%4.8%5.7 $5.11 7/30/20214,770,000 shares $23.52 million -0.6%5.0%5.6 $4.93White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 7/15/20214,800,000 shares $20.93 million +12.4%5.0%5.4 $4.36 6/30/20214,270,000 shares $21.86 million -5.3%4.5%5 $5.12 6/15/20214,510,000 shares $25.71 million -0.4%4.7%4.8 $5.70 5/28/20214,530,000 shares $25.64 million +2.0%4.8%3.7 $5.66 5/14/20214,440,000 shares $24.33 million -31.2%4.7%2.3 $5.48 4/30/20216,450,000 shares $36.57 million +57.7%6.8%3.2 $5.67 4/15/20214,090,000 shares $23.80 million +29.4%4.3%2 $5.82 3/31/20213,160,000 shares $21.05 million -43.6%3.3%1.5 $6.66 3/15/20215,600,000 shares $33.71 million +2.8%5.9%2.8 $6.02 2/26/20215,450,000 shares $26.65 million -9.9%5.8%3.1 $4.89 2/12/20216,050,000 shares $35.70 million +21.2%6.4%5.1 $5.90 1/29/20214,990,000 shares $24.60 million -18.1%5.3%4.2 $4.93 1/15/20216,090,000 shares $29.54 million +19.4%6.4%5.2 $4.85 12/31/20205,100,000 shares $23.46 million -21.9%5.4%4.3 $4.60 12/15/20206,530,000 shares $28.67 million +2.5%6.9%5.7 $4.39 11/30/20206,370,000 shares $25.93 million -3.6%6.7%5.5 $4.07 11/15/20206,610,000 shares $27.37 million +7.0%7.0%5.6 $4.14 10/30/20206,180,000 shares $26.94 million -1.3%6.5%5.4 $4.36 10/15/20206,260,000 shares $30.61 million -12.7%6.6%5.5 $4.89 9/30/20207,170,000 shares $27.82 million -4.5%7.6%6.3 $3.88 9/15/20207,510,000 shares $30.34 million +8.7%8.0%6.4 $4.04 8/31/20206,910,000 shares $28.40 million -0.1%7.3%5.5 $4.11 8/14/20206,920,000 shares $29.41 million -3.4%7.3%4.9 $4.25 7/31/20207,160,000 shares $31.00 million +2.6%7.6%4.2 $4.33 7/15/20206,980,000 shares $32.60 million -5.6%7.4%4.2 $4.67 6/30/20207,390,000 shares $35.18 million +26.8%7.8%4.3 $4.76 6/15/20205,830,000 shares $25.42 million -4.3%6.2%3 $4.36 5/29/20206,090,000 shares $29.48 million -9.2%6.5%2.8 $4.84 AMRX Short Interest - Frequently Asked Questions What is Amneal Pharmaceuticals' current short interest? Short interest is the volume of Amneal Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 5,360,000 shares of AMRX short. 3.73% of Amneal Pharmaceuticals' shares are currently sold short. Learn More on Amneal Pharmaceuticals' current short interest. What is a good short interest ratio for Amneal Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMRX shares currently have a short interest ratio of 3.0. Learn More on Amneal Pharmaceuticals's short interest ratio. Which institutional investors are shorting Amneal Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amneal Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Amneal Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.73% of Amneal Pharmaceuticals' floating shares are currently sold short. Is Amneal Pharmaceuticals' short interest increasing or decreasing? Amneal Pharmaceuticals saw a decline in short interest in May. As of May 15th, there was short interest totaling 5,360,000 shares, a decline of 12.1% from the previous total of 6,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Amneal Pharmaceuticals' float size? Amneal Pharmaceuticals currently has issued a total of 313,420,000 shares. Some of Amneal Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amneal Pharmaceuticals currently has a public float of 143,560,000 shares. How does Amneal Pharmaceuticals' short interest compare to its competitors? 3.73% of Amneal Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Amneal Pharmaceuticals: Roivant Sciences Ltd. (11.23%), Revolution Medicines, Inc. (12.20%), Blueprint Medicines Co. (9.26%), BridgeBio Pharma, Inc. (15.63%), Elanco Animal Health Incorporated (5.58%), Verona Pharma plc (10.60%), Grifols, S.A. (1.46%), TG Therapeutics, Inc. (16.20%), Legend Biotech Co. (4.15%), Nuvalent, Inc. (13.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Amneal Pharmaceuticals stock? Short selling AMRX is an investing strategy that aims to generate trading profit from Amneal Pharmaceuticals as its price is falling. AMRX shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amneal Pharmaceuticals? A short squeeze for Amneal Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMRX, which in turn drives the price of the stock up even further. How often is Amneal Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMRX, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies Roivant Sciences Short Interest Data Revolution Medicines Short Interest Data Blueprint Medicines Short Interest Data BridgeBio Pharma Short Interest Data Elanco Animal Health Short Interest Data Verona Pharma Short Interest Data Grifols Short Interest Data TG Therapeutics Short Interest Data Legend Biotech Short Interest Data Nuvalent Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMRX) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMRX Stock Free AMRX Stock Alerts